Samenvatting
This chapter explores on the role of epigenetic pathways in cardiovascular disease, with a particular focus on providing an overview of DNA methylation involvement. The text encompasses the biology and mechanics of DNA methylation process and its significance in the context of cardiovascular disease conditions. Numerous epidemiological studies reported DNA methylation as the principal risk factor that establishes a link between epigenomic components and the development of disease phenotypes. Methylation represents a fundamental step in the evolutionary trajectory of cardiovascular physiology, and this epigenetic alteration holds promise as both a predictive and diagnostic marker. Additionally, considering the potential to modulate epigenetic processes, this chapter underscores and elucidates the current and potential treatment strategies for cardiovascular disease at various stages, ranging from preclinical to clinical phases.
| Originele taal-2 | Engels |
|---|---|
| Titel | Pharmacoepigenetics |
| Uitgeverij | Elsevier |
| Pagina's | 903-918 |
| Aantal pagina's | 16 |
| ISBN van elektronische versie | 9780443187223 |
| ISBN van geprinte versie | 9780443187230 |
| DOI's | |
| Status | Gepubliceerd - 1 jan 2025 |
Vingerafdruk
Duik in de onderzoeksthema's van 'Role of DNA methylation in cardiovascular disease'. Samen vormen ze een unieke vingerafdruk.Citeer dit
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver